Background illustration for clinical trials search

Paid Clinical Trials Connecticut

Discover 1,167 paid clinical trials in Connecticut. Search by city or condition to find a research study near you that matches your needs across various therapeutic areas.

Filter
1
Active & Responsive

A Clinical Trial of EYE201/MK-8748 in People With Macular Degeneration (MK-8748-003)

for
Macular Degeneration, Age-Related Macular Degeneration,
Location: Portland ME, Waterford CT, Manchester CT,
Sponsor: EyeBiotech Ltd.

Sex: All

Age: 50+

Code: NCT07496567

Phase 2, Phase 3, Recruiting
Active & Responsive

A Study to Assess the Tolerability of Ianalumab (VAY736) With Investigator's Choice Thrombopoietin Receptor Agonist (IC TPO-RA) in Patients With Primary Immune Thrombocytopenia (ITP)

for
Primary Immune Thrombocytopenia (ITP),
Location: New Haven CT, Stamford CT, The Bronx NY, Summit NJ,
Sponsor: Novartis Pharmaceuticals

Sex: All

Age: 18+

Code: NCT07421167

Phase 2, Recruiting
Active & Responsive

Project STRONGER: Stepped Care for Opioid Use Disorder Treatment Engagement and Recovery

for
Opioid Use Disorder, Intimate Partner Violence (IPV),
Location: West Haven CT, Bridgeport CT
Sponsor: Yale University

Sex: Female

Age: 18+

Code: NCT07115030

Recruiting
Active & Responsive

A Pancreatic Cancer Screening Study in Individuals With New-Onset or Deteriorating Diabetes Mellitus

for
Pancreatic Cancer, Pancreatic Neoplasms, Diabetes Mellitus
Location: Norwalk CT
Sponsor: Nuvance Health

Sex: All

Age: 50+

Code: NCT03937453

Recruiting
Active & Responsive

Preoperative Exercise Testing and Perioperative Outcomes

for
Postoperative Complications (Cardiopulmonary)
Location: New Haven CT
Sponsor: Yale University

Sex: All

Age: 45+

Code: NCT07519733

Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image
Active & Responsive

A Randomized Phase 1/2 Trial of Low Dose Anti-thymocyte Globulin (ATG) With Subsequent Adalimumab or Verapamil in New Onset Type 1 Diabetes

for
Type 1 Diabetes, New Onset
Location: New Haven CT, Miami FL, Buffalo NY, Pittsburgh PA,
Sponsor: City of Hope Medical Center

Sex: All

Age: 9 - 20

Code: NCT07061574

Phase 1, Phase 2, Recruiting
Active & Responsive

A Study of ELA026 in Participants With Relapsed/Refractory (R/R) T/NK Cell Malignancies (TCMs)

for
T Cell Malignancies
Location: New Haven CT, New York NY, Cleveland OH, Atlanta GA,
Sponsor: Electra Therapeutics Inc.

Sex: All

Age: 18+

Code: NCT07465835

Phase 1, Recruiting
Active & Responsive

Rezpegaldesleukin (NKTR-358) in New Onset Type 1 Diabetes Mellitus

for
Type 1 Diabetes Mellitus
Location: Boston MA, New Haven CT, New York NY, Miami FL,
Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Sex: All

Age: 8 - 45

Code: NCT07142252

Phase 2, Recruiting
Active & Responsive

Study of Silevertinib With Temozolomide for the Treatment of Newly Diagnosed GBM With Unmethylated MGMT and EGFRvIII

for
Glioblastoma (GBM), Newly Diagnosed Glioblastoma, GBM,
Location: Scarborough ME, Boston MA, New Haven CT,
Sponsor: Black Diamond Therapeutics, Inc.

Sex: All

Age: 18+

Code: NCT07326566

Phase 2, Recruiting
Active & Responsive

Efficacy and Safety Evaluation of VS-101 in Combination With Chemoradiotherapy in Patients With Head and Neck Cancer

for
Head and Neck Cancer Squamous Cell Carcinoma
Location: New Haven CT, Manhattan NY
Sponsor: VSPharmTech Co.,Ltd.

Sex: All

Age: 18+

Code: NCT06959082

Phase 2, Recruiting
Active & Responsive

Life at 100.4: An Immersive Social Virtual Reality (VR) Education Tool for Adolescent and Young Adult Cancer Patients and Caregivers

for
Cancer, Adolescent Cancer, Young Adult Cancer
Location: New Haven CT
Sponsor: Yale University

Sex: All

Age: 13 - 39

Code: NCT07224204

Recruiting
Active & Responsive

Study of RAS(ON) Inhibitors in Combination With Ivonescimab in Patients With Solid Tumors

for
Advanced Solid Tumors, Metastatic Solid Tumors,
Location: Norwich CT, New York NY, Hackensack NJ, Fairfax VA,
Sponsor: Revolution Medicines, Inc.

Sex: All

Age: 18+

Code: NCT07397338

Phase 1, Phase 2, Recruiting
Active & Responsive

Zymfentra (Infliximab-dyyb) REal World Cohort STudy

for
Ulcerative Colitis (UC), Crohn's Disease (CD),
Location: Boston MA, New Haven CT, New York NY, Baltimore MD,
Sponsor: University of North Carolina, Chapel Hill

Sex: All

Age: 18+

Code: NCT07237516

Recruiting
Active & Responsive

FIH Study to Evaluate Safety, Tolerability, PK, PD & Preliminary Efficacy of AT03-65 With Advanced Solid Tumors

for
Solid Tumor
Location: New Haven CT, Charleston SC, Denver CO, Portland OR
Sponsor: Axcynsis Therapeutics Pte Ltd

Sex: All

Age: 18+

Code: NCT06809114

Phase 1, Recruiting
Active & Responsive

A Study to Assess the Safety, Tolerability, Efficacy, Pharmacokinetics, and Immunogenicity of Intravenous Administration of ARGX-119 in Pediatric Participants Aged 5 to Less Than 18 Years With Spinal Muscular Atrophy

for
Spinal Muscular Atrophy (SMA)
Location: Boston MA, Hartford CT, New York NY, Hillsborough NC,
Sponsor: argenx

Sex: All

Age: 5 - 17

Code: NCT07287982

Phase 2, Recruiting
Active & Responsive

A Study to Assess the Safety, Tolerability, Pharmacokinetic, Pharmacodynamic, Immunogenicity and Antitumour Activity of IPN60300 in Adults With Locally Advanced or Metastatic Solid Tumours

for
Locally Advanced Solid Tumor, Metastatic Solid Tumor
Location: New Haven CT, Philadelphia PA, Fairfax VA,
Sponsor: Ipsen

Sex: All

Age: 18+

Code: NCT07213817

Phase 1, Phase 2, Recruiting
Active & Responsive

Identification of Brain Injury Using Portable MRI

for
Cardiac Arrest (CA), Hypoxic-Ischemic Brain Injury
Location: New Haven CT
Sponsor: Yale University

Sex: All

Age: 18+

Code: NCT07197918

Recruiting
Active & Responsive

A Trial Investigating the Efficacy and Safety of NVG-291 in Subjects With Chronic Spinal Cord Injury

for
Chronic Spinal Cord Injury
Location: Stamford CT, Lutherville MD, Atlanta GA, Englewood CO
Sponsor: NervGen Pharma

Sex: All

Age: 18 - 70+

Code: NCT07799532

Phase 3, Recruiting
Active & Responsive

Language Network Prehab Via fMRI Neurofeedback

for
Glioma, Glioma Surgery
Location: New Haven CT
Sponsor: Yale University

Sex: All

Age: 18+

Code: NCT07488780

Recruiting
Active & Responsive

A Clinical Trial of MK-8748 Compared to Aflibercept in Participants With Diabetic Macular Edema (MK-8748-004)

for
Diabetic Retinopathy, Macular Edema
Location: Manchester CT, Springfield MA, Bloomfield NJ,
Sponsor: Merck Sharp & Dohme LLC

Sex: All

Age: 18+

Code: NCT07705555

Phase 3, Recruiting

Popular cities in Connecticut

Connecticut stands out as a prime location for a wide variety of clinical trials, largely thanks to its robust healthcare system and renowned medical research institutions. Leading centers like Yale School of Medicine, UConn Health, and Jackson Laboratory for Genomic Medicine are at the forefront of groundbreaking studies in the state.

Combining a strong focus on innovation and precision medicine makes Connecticut an ideal destination for participants seeking advanced medical treatments and the opportunity to contribute to cutting-edge research.

Why choose Connecticut for clinical trials?

With a diverse and highly educated population, Connecticut offers distinct advantages for those participating in clinical trials, including the opportunity to enhance the reliability and depth of research findings. The vibrant population here makes clinical studies in Connecticut more comprehensive and representative.

By choosing to participate in a clinical trial in Connecticut, individuals contribute to groundbreaking medical research while benefiting from a well-established and supportive clinical research infrastructure, ultimately advancing healthcare for all.

Common conditions studied in Connecticut

Local regulations and guidelines

Benefits of participating in clinical trials

How to enroll in a clinical trial in Connecticut